Every 20 seconds, someone loses a limb to diabetes-related complications. We're here to change that.
Our cutting-edge AI-powered thermal imaging technology revolutionizes diabetic foot screening—making it faster, more accessible, and truly objective. With this innovation, healthcare teams can detect early signs of complications before they become critical.
No more waiting. No more uncertainty. Just fast, confident decisions that can save limbs—and lives
Ultrasound is the primary tool for diagnosing ovarian cancer, as biopsies are not feasible. However, the accuracy of ultrasound is highly dependent on the operator’s expertise. This variability contributes to late diagnoses in 75% of cases—leading to survival rates below 40%. In contrast, early detection can raise survival chances to over 80%, highlighting the urgent need for more objective and reliable diagnostic tools.
Fast. Accurate. Effortless.
Easily capture high-resolution thermal images of the foot in just seconds using our lightweight, portable camera. Designed for speed and simplicity, this tool allows healthcare professionals to begin screenings instantly—anytime, anywhere—with no need for complex setups or specialized environments.
Immediately receive AI-generated insights supported by clinical data and international standards, including risk classification based on the International Working Group on the Diabetic Foot (IWGDF). Our multi-modal analysis provides a comprehensive view of patient risk, helping clinicians make faster, more confident decisions.
Track each patient’s condition over time through our centralized digital portal. Monitor healing progress, detect early signs of complications, and review historical data to guide treatment decisions. With easy access to patient records and visual trends, long-term care becomes more proactive and personalized.
